VIE/SHL (VIE/SHL)

Vienna Stock Exchange: VIE/SHL · EUR

€42.6

+0.69 (+1.6%)· Recorded snapshot

Market cap	47.4B
Revenue (ttm)	23.2B
Net income (ttm)	2.2B
EPS (ttm)	€1.97
P/E (trailing)	21.6x
P/E (forward)	18.3x
Dividend	€1.00 (2.35%)
Volume	1,290

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 23.2B
Net income (ttm): 2.2B
EPS (ttm): €1.97
P/E (trailing): 21.6x
P/E (forward): 18.3x
Market cap: 47.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E18.3

P25 n/aP50 n/aP75 n/a

Trailing P/E21.6

P25 n/aP50 n/aP75 n/a

ROE12.1

P25 n/aP50 n/aP75 n/a

ROIC7.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/SHL indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

EUR

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-11-05
Employees	74,300
Employees change	-40
Employees growth	-0.05%
Enterprise value	EUR 60.1B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Founded	1896
Industry	Medical Devices
Is primary listing	No
ISIN number	DE000SHL1006
Last earnings date	2026-07-31
Last refreshed	2026-10-29
Market cap	EUR 47.4B
Next earnings date	2026-11-05
Price	EUR 42.61
Price currency	EUR
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	vie/SHL
Website	https://www.siemens-healthineers.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	29.23x
Average P/E ratio (3Y)	27.96x
Average P/E ratio (5Y)	30.1x
Earnings yield	4.63%
EV/Earnings	27.16x
EV/EBIT	18.62x
EV/EBITDA	14.23x
EV/FCF	23.06x
EV/Sales	2.59x
FCF / EV yield	4.34%
FCF yield	5.5%
Forward P/E	18.34x
Graham number	27.76367
Graham upside	-34.84%
Lynch fair value	EUR 10.92
Lynch upside	-74.37%
P/B ratio	2.47x
P/E ratio	21.58x
P/FCF ratio	18.18x
P/OCF ratio	13.85x
P/S ratio	2.05x
Price/EBITDA ratio	11.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	13.98%
EBITDA margin	17.36%
Effective tax rate	22.6%
FCF margin	11.25%
Gross margin	39.02%
Operating margin	13.98%
Pretax margin	12.49%
Profit margin	9.55%
Profit per employee	EUR 29,785
Profitable quarters	39
Profitable years	11
Revenue per employee	EUR 311,817
ROA	4.48%
ROA (5Y)	3.95%
ROCE	9.85%
ROE	12.15%
ROE (5Y)	10.88%
ROIC	7.9%
ROIC (5Y)	6.84%
Tax / revenue	2.82%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	2.32%
EPS growth (Q)	22.45%
EPS growth (QoQ)	33.33%
EPS growth 3Y	11.62%
EPS growth 5Y	4.59%
EPS growth quarters	1
EPS growth years	2
FCF growth	-15.25%
FCF growth (Q)	21.21%
FCF growth (QoQ)	162.98%
FCF growth 3Y	30.32%
FCF growth 5Y	0.15%
Gross profit growth	-0.26%
Gross profit growth (Q)	12.33%
Gross profit growth 3Y	5.32%
Gross profit growth 5Y	7.05%
Net income growth	1.89%
Net income growth (Q)	21.2%
Net income growth (QoQ)	32.21%
Net income growth 3Y	11.35%
Net income growth 5Y	5.49%
Net income growth quarters	1
Net income growth years	2
OCF growth	-11.02%
OCF growth (Q)	19.13%
OCF growth (QoQ)	115.56%
OCF growth 3Y	18.45%
OCF growth 5Y	1.26%
Operating income growth	0.62%
Operating income growth (Q)	29.23%
Operating income growth 3Y	14.59%
Operating income growth 5Y	5.53%
Revenue growth	-0.92%
Revenue growth (Q)	1.8%
Revenue growth (QoQ)	1.48%
Revenue growth 3Y	2.33%
Revenue growth 5Y	6.75%
Revenue growth quarters	1
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -815M
Depreciation and amortization	EUR 784M
EBIT	EUR 3.2B
EBITDA	EUR 4B
EPS	EUR 1.97
Financing cash flow	EUR -2.7B
Free cash flow	EUR 2.6B
Gross profit	EUR 9B
Income taxes	EUR 654M
Investing cash flow	EUR -737M
Net borrowing	EUR -992M
Net cash flow	EUR -14M
Net income	EUR 2.2B
Operating income	EUR 3.2B
Revenue	EUR 23.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.97
Book value per share	EUR 17.13
Debt / EBITDA	3.54
Debt / equity	0.78
Debt / FCF	5.75
Goodwill	EUR 17.4B
Interest coverage	7.96
Long-term assets	EUR 30.8B
Long-term liabilities	EUR 13.7B
Net cash (debt)	EUR -12.6B
Net cash / market cap	-26.67%
Net debt / EBITDA	3.14
Net debt / equity	0.66
Net debt / FCF	4.85
Piotroski F-Score	7
Property, plant and equipment	EUR 4.9B
Shareholders' equity	EUR 19.2B
Tangible book value	EUR -4.8B
Tangible book value per share	EUR -4.31
Total assets	EUR 45.7B
Total cash	EUR 2.4B
Total debt	EUR 15B
Total liabilities	EUR 26.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	EUR 15B
Current liabilities	EUR 12.9B
Current ratio	1.16
Inventory turnover	3.1
Net working capital	EUR 3.2B
Quick ratio	0.7
Working capital	EUR 2.1B
Working capital turnover	12.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.49%
Dividend growth	5.26%
Dividend growth (3Y)	1.72%
Dividend growth (5Y)	4.56%
Dividend growth years	0
Dividend payment date	2026-02-10
Dividend payment years	8
Dividend payout frequency	Annual
Dividend per share	EUR 1.00
Dividend yield	2.35%
Ex-dividend date	2026-02-06
Last dividend	EUR 1.00
Payout ratio	50.52%
Shareholder yield	2.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 36.92
1D price change	1.65%
1M price change	12.96%
1M total return	12.96%
1W price change	2.92%
1W total return	2.92%
1Y price change	-13.88%
1Y return CAGR	-11.83%
1Y total return	-11.82%
20-day SMA	EUR 39.95
200-day SMA	EUR 37.92
3M price change	19.39%
3M total return	19.39%
3Y price change	-7.19%
3Y return CAGR	-0.51%
3Y total return	-1.53%
50-day SMA	EUR 39.30
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 49.45
52-week high date	2025-10-28
52-week low	EUR 32.95
52-week low date	2026-05-18
5Y price change	-27.9%
5Y return CAGR	-4.57%
5Y total return	-20.86%
6M price change	19.73%
6M total return	19.73%
All-time high	EUR 67.42
All-time high date	2021-12-09
All-time low	EUR 29.04
All-time low date	2018-03-16
Average true range (ATR)	EUR 0.63
Average volume	161.3
Change from 52-week high	-13.83%
Change from 52-week low	29.32%
Change from all-time high	-36.8%
Change from all-time low	46.73%
Change from open	1.77%
Day's gap	-0.12%
Dollar volume	EUR 54,967
High price	EUR 42.61
Low price	EUR 41.82
Monthly RSI	48.66
Open price	EUR 41.87
Position in 52-week range	100%
Previous close	EUR 41.92
Price vs 150-day SMA	15.42%
Price vs 20-day SMA	6.66%
Price vs 200-day SMA	12.36%
Price vs 50-day SMA	8.42%
Relative volume	8
RSI	71.22
Sharpe ratio	-0.49
Sharpe ratio (3Y)	-0.1
Sharpe ratio (5Y)	-0.22
Sortino ratio	-0.44
Sortino ratio (3Y)	0.11
Sortino ratio (5Y)	-0.1
Volume	1.3K
Weekly RSI	67.25
YTD price change	-4.65%
YTD total return	-2.37%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	357.1M
Shares change (QoQ)	-0.84%
Shares change (YoY)	-0.49%
Shares held by institutions	12.71%

Deeper analysis on VIE/SHL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/SHL report

Is a complete VIE/SHL research report available?

No complete published report is available for vie/SHL (VIE/SHL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/SHL (VIE/SHL)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/SHL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/SHL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/SHL

Frequently asked questions